Cargando…

Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation?

OBJECTIVE: The aim of this work was to investigate whether there are differences in the executive control network (ECN) between patients with Parkinson's disease (PD) before and after deep brain stimulation (DBS) surgery and to explore how deep brain stimulation (DBS) surgery affects ECN connec...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Wenwen, Qiu, Chang, Jiang, Xu, Shen, Bo, Zhang, Li, Liu, Weiguo, Zhang, Wenbin, Chen, Jiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042555/
https://www.ncbi.nlm.nih.gov/pubmed/32148755
http://dx.doi.org/10.1155/2020/6348102
_version_ 1783501326785708032
author Dong, Wenwen
Qiu, Chang
Jiang, Xu
Shen, Bo
Zhang, Li
Liu, Weiguo
Zhang, Wenbin
Chen, Jiu
author_facet Dong, Wenwen
Qiu, Chang
Jiang, Xu
Shen, Bo
Zhang, Li
Liu, Weiguo
Zhang, Wenbin
Chen, Jiu
author_sort Dong, Wenwen
collection PubMed
description OBJECTIVE: The aim of this work was to investigate whether there are differences in the executive control network (ECN) between patients with Parkinson's disease (PD) before and after deep brain stimulation (DBS) surgery and to explore how deep brain stimulation (DBS) surgery affects ECN connectivity in patients with PD. METHODS: Resting-state magnetic resonance imaging (MRI) data were obtained from 23 patients with Parkinson's disease preoperatively (pre-PD) and postoperatively (post-PD) and 14 normal controls (CN). The right dorsolateral prefrontal cortex (DLPFC) was used as the seed region of interest (ROI) to study the characteristics of the functional connectivity of the ECN in these subjects. RESULTS: There were differences in the ECN among PD patients before and after surgery and between the CN. Compared with the CN group, the pre-PD patients showed significantly reduced functional connectivity (FC) between the DLPFC and the left inferior frontal gyrus, left precuneus, left cerebellum posterior lobe, right middle frontal gyrus, right inferior parietal gyrus, right posterior central gyrus, right precuneus, and right inferior frontal gyrus. Compared to the CN group, the post-PD patients showed significantly reduced FC between the DLPFC and left inferior frontal gyrus, left precuneus, left cerebellum posterior lobe, right middle frontal gyrus, right inferior frontal gyrus, and right parietal lobule. There is no difference in the ECN between the pre-PD patients and the post-PD patients. CONCLUSIONS: The FC of ECN in PD patients was different from that in normal controls, but the FC of the ECN in patients with PD may not be altered by DBS. This suggests that the ECN may be considered an imaging biomarker for the identification of PD but may not be a good imaging biomarker for the evaluation of DBS efficacy.
format Online
Article
Text
id pubmed-7042555
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70425552020-03-07 Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation? Dong, Wenwen Qiu, Chang Jiang, Xu Shen, Bo Zhang, Li Liu, Weiguo Zhang, Wenbin Chen, Jiu Parkinsons Dis Research Article OBJECTIVE: The aim of this work was to investigate whether there are differences in the executive control network (ECN) between patients with Parkinson's disease (PD) before and after deep brain stimulation (DBS) surgery and to explore how deep brain stimulation (DBS) surgery affects ECN connectivity in patients with PD. METHODS: Resting-state magnetic resonance imaging (MRI) data were obtained from 23 patients with Parkinson's disease preoperatively (pre-PD) and postoperatively (post-PD) and 14 normal controls (CN). The right dorsolateral prefrontal cortex (DLPFC) was used as the seed region of interest (ROI) to study the characteristics of the functional connectivity of the ECN in these subjects. RESULTS: There were differences in the ECN among PD patients before and after surgery and between the CN. Compared with the CN group, the pre-PD patients showed significantly reduced functional connectivity (FC) between the DLPFC and the left inferior frontal gyrus, left precuneus, left cerebellum posterior lobe, right middle frontal gyrus, right inferior parietal gyrus, right posterior central gyrus, right precuneus, and right inferior frontal gyrus. Compared to the CN group, the post-PD patients showed significantly reduced FC between the DLPFC and left inferior frontal gyrus, left precuneus, left cerebellum posterior lobe, right middle frontal gyrus, right inferior frontal gyrus, and right parietal lobule. There is no difference in the ECN between the pre-PD patients and the post-PD patients. CONCLUSIONS: The FC of ECN in PD patients was different from that in normal controls, but the FC of the ECN in patients with PD may not be altered by DBS. This suggests that the ECN may be considered an imaging biomarker for the identification of PD but may not be a good imaging biomarker for the evaluation of DBS efficacy. Hindawi 2020-02-14 /pmc/articles/PMC7042555/ /pubmed/32148755 http://dx.doi.org/10.1155/2020/6348102 Text en Copyright © 2020 Wenwen Dong et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dong, Wenwen
Qiu, Chang
Jiang, Xu
Shen, Bo
Zhang, Li
Liu, Weiguo
Zhang, Wenbin
Chen, Jiu
Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation?
title Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation?
title_full Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation?
title_fullStr Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation?
title_full_unstemmed Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation?
title_short Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation?
title_sort can the executive control network be used to diagnose parkinson's disease and as an efficacy indicator of deep brain stimulation?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042555/
https://www.ncbi.nlm.nih.gov/pubmed/32148755
http://dx.doi.org/10.1155/2020/6348102
work_keys_str_mv AT dongwenwen cantheexecutivecontrolnetworkbeusedtodiagnoseparkinsonsdiseaseandasanefficacyindicatorofdeepbrainstimulation
AT qiuchang cantheexecutivecontrolnetworkbeusedtodiagnoseparkinsonsdiseaseandasanefficacyindicatorofdeepbrainstimulation
AT jiangxu cantheexecutivecontrolnetworkbeusedtodiagnoseparkinsonsdiseaseandasanefficacyindicatorofdeepbrainstimulation
AT shenbo cantheexecutivecontrolnetworkbeusedtodiagnoseparkinsonsdiseaseandasanefficacyindicatorofdeepbrainstimulation
AT zhangli cantheexecutivecontrolnetworkbeusedtodiagnoseparkinsonsdiseaseandasanefficacyindicatorofdeepbrainstimulation
AT liuweiguo cantheexecutivecontrolnetworkbeusedtodiagnoseparkinsonsdiseaseandasanefficacyindicatorofdeepbrainstimulation
AT zhangwenbin cantheexecutivecontrolnetworkbeusedtodiagnoseparkinsonsdiseaseandasanefficacyindicatorofdeepbrainstimulation
AT chenjiu cantheexecutivecontrolnetworkbeusedtodiagnoseparkinsonsdiseaseandasanefficacyindicatorofdeepbrainstimulation